External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Inflammatory Disease UEGW 2026
Roche and Genentech at

UEGW 2026

October 17 - October 20
Barcelona, Spain
ueg.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
07:00 AM
Duration 60mins Barcelona, Spain
Delineating the Unique and Non-Redundant Molecular Signatures of TL1A, IL-23, and TNF Signalling in Human T-Cell Subsets
Franklin Fuh, Meng Sun, Effi Kenigsberg, Claire McHugh, Sharmila Chatterjee, Vishnu Mohanan
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Barcelona, Spain
Indirect Comparison of Afimkibart and Adalimumab Treatment Effects Using Data From TUSCANY-2 and HIBISCUS in Patients With Ulcerative Colitis
Daniela Bojic, Qixiang Xu, Vishal A. Manickam, Yihao Li, Steven Levitte, Jiameng Zhang, Anindita Banerjee, Deepa E. Chandra, Elena Peeva, Srividya Neelakantan, Michael S. Vincent, K. T. Park
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Barcelona, Spain
Treatment Patterns Among Patients With Moderate to Severe Ulcerative Colitis Treated in Routine Clinical Practice in the United States
Sheila Shapouri, Achal Patel, Robert Schuldt, Tara Fehlmann, Ben Kostiuk, Nikki Win, Norelle Riley, Oliwia Zurek
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:30 PM
Duration 60mins Barcelona, Spain
Change the Game: Decoding the Domino Effect Behind Ulcerative Colitis Progression
Prof. Laurent Peyrin-Biroulet, Prof. Marla Dubinsky, Prof. David Rubin
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 AM
Duration 60mins Barcelona, Spain
Symptomatic Remission and Health-Related Quality of Life With Afimkibart Treatment for Moderately to Severely Active Ulcerative Colitis in the Phase 2b TUSCANY-2 Trial
Laurent Peyrin-Biroulet
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 AM
Duration 60mins Barcelona, Spain
Evaluation of changes in gene expression in colonic biopsies from patients treated with afimkibart in the TUSCANY-2 trial
Margaret Neighbors
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Barcelona, Spain
Functional Differentiation of Afimkibart’s Preference for Trimeric TL1A in Blocking Active TL1A Signalling
Vishnu Mohanan
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.